This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jan;28(1):77-78.

doi: 10.5152/tjg.2016.25122016.

Rifaximin in treatment of patients with Irritable bowel syndrome

Bhupinder Romana¹, Veysel Tahan

Affiliations

PMID: 28134620
DOI: 10.5152/tjg.2016.25122016

Free article

Comment

Rifaximin in treatment of patients with Irritable bowel syndrome

Bhupinder Romana et al. Turk J Gastroenterol. 2017 Jan.

Free article

. 2017 Jan;28(1):77-78.

doi: 10.5152/tjg.2016.25122016.

Authors

Bhupinder Romana¹, Veysel Tahan

Affiliation

¹ Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, Missouri, USA. tahanv@health.missouri.edu.

PMID: 28134620
DOI: 10.5152/tjg.2016.25122016

No abstract available

PubMed Disclaimer

Comment on

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, Paterson C, Bortey E, Forbes WP. Lembo A, et al. Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13. Gastroenterology. 2016. PMID: 27528177 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Aves Yayincilik
Other Literature Sources
- scite Smart Citations